Endovia Health Sciences, Inc. (EDVA) — Institutional Holders, Q2 2026
18 institutional investment managers reported a EDVA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $172.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EDVA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPNew · +348,418 sh+$54.0K
- Point72 Asset Management, L.P.New · +56,950 sh+$8.8K
- Phraction ManagementAdded · +53,648 sh+$8.3K
- TRUIST FINANCIALAdded · +35,000 sh+$5.4K
- StoneX GroupNew · +28,151 sh+$4.4K
Biggest sellers
- HRT FINANCIALTrimmed · -77,769 sh-$12.1K
- UBS Group AGSold out · -53,111 sh-$8.2K
- Virtu FinancialTrimmed · -40,288 sh-$6.2K
- CITADEL ADVISORSSold out · -16,585 sh-$2.6K
- Vanguard Global AdvisersSold out · -152 sh-$24.00
EDVA 13F holders ranked 1–18 of 18
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 348,418 sh | 348,418 | $54.0K | 0.00% | New |
| 2 | Phraction Management#2 · 123,648 sh | 123,648 | $19.2K | — | +76.6% |
| 3 | Summit Trail Advisors#3 · 100,000 sh | 100,000 | $15.5K | <0.01% | 0.0% |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 68,591 sh | 68,591 | $10.6K | 0.00% | +19.4% |
| 5 | TRUIST FINANCIAL#5 · 67,819 sh | 67,819 | $10.5K | 0.00% | +106.6% |
| 6 | Lifetime Wealth Management P.C.#6 · 66,050 sh | 66,050 | $10.2K | <0.01% | 0.0% |
| 7 | COMPASS FINANCIAL MANAGEMENT#7 · 64,500 sh | 64,500 | $10.0K | <0.01% | — |
| 8 | Virtu Financial#8 · 59,897 sh | 59,897 | $9.0K | <0.01% | -40.2% |
| 9 | Point72 Asset Management, L.P.#9 · 56,950 sh | 56,950 | $8.8K | 0.00% | New |
| 10 | HRT FINANCIAL#10 · 56,687 sh | 56,687 | $8.0K | 0.00% | -57.8% |
| 11 | StoneX Group#11 · 28,151 sh | 28,151 | $5.4K | <0.01% | New |
| 12 | CHOREO#12 · 34,027 sh | 34,027 | $5.3K | <0.01% | 0.0% |
| 13 | GOLDMAN SACHS GROUP#13 · 20,405 sh | 20,405 | $3.2K | 0.00% | New |
| 14 | VANGUARD CAPITAL MANAGEMENT#14 · 10,934 sh | 10,934 | $1.7K | 0.00% | 0.0% |
| 15 | Tower Research Capital (TRC)#15 · 4,019 sh | 4,019 | $623.00 | 0.00% | 0.0% |
| 16 | HARBOUR INVESTMENTS#16 · 470 sh | 470 | $73.00 | 0.00% | New |
| 17 | Delos Wealth Advisors#17 · 16 sh | 16 | $3.00 | 0.00% | 0.0% |
| 18 | SBI Securities , Ltd.#18 · 5 sh | 5 | $1.00 | — | -93.2% |
Funds that sold out of EDVA in Q2 2026 (4)
Held EDVA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| UBS Group AG53,111 sh | 53,111 | $19.1K |
| CITADEL ADVISORS16,585 sh | 16,585 | $6.0K |
| Vanguard Global Advisers152 sh | 152 | $55.00 |
| CITIGROUP1 sh | 1 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.